We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Diabetes

Journal Scan / Research · April 14, 2020

Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Patients With Type 2 Diabetes

Diabetes Care

 

Additional Info

Diabetes Care
A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial
Diabetes Care 2020 Apr 09;[EPub Ahead of Print], FJ Pasquel, MC Lansang, A Khowaja, MA Urrutia, S Cardona, B Albury, RJ Galindo, M Fayfman, G Davis, A Migdal, P Vellanki, L Peng, GE Umpierrez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading